Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY – Get Free Report) hit a new 52-week low on Tuesday . The stock traded as low as $9.51 and last traded at $9.51, with a volume of 415 shares changing hands. The stock had previously closed at $9.70.
Ambu A/S Trading Down 2.0%
The company has a debt-to-equity ratio of 0.08, a current ratio of 2.92 and a quick ratio of 1.73. The business has a 50-day moving average of $10.13 and a 200-day moving average of $11.76. The firm has a market cap of $2.23 billion, a price-to-earnings ratio of 33.96 and a beta of 0.99.
Ambu A/S (OTCMKTS:AMBBY – Get Free Report) last issued its quarterly earnings results on Wednesday, May 6th. The company reported $0.07 EPS for the quarter. The firm had revenue of $246.39 million during the quarter. Ambu A/S had a return on equity of 8.03% and a net margin of 7.81%.
Ambu A/S Company Profile
Ambu A/S is a Denmark-based medical device company specializing in single-use diagnostic and life-supporting equipment for hospitals, clinics and emergency services. The company’s core focus lies in developing products that enhance patient safety, streamline clinical workflows and reduce the risk of cross-contamination. Ambu’s offerings span critical care solutions such as anesthesia and respiratory care devices, as well as advanced endoscopy systems for minimally invasive diagnostics and therapies.
Within its anesthesia and respiratory care segment, Ambu is known for its market-leading disposable resuscitators—commonly referred to as “Ambu bags”—as well as a range of airway management products, including laryngeal masks and endotracheal tubes.
Featured Articles
- Five stocks we like better than Ambu A/S
- Buy CrowdStrike Before the Stock Split? Here’s the Case
- Investors Are Buying Into Sweetgreen Again—Should They?
- Burlington Is Winning Over Shoppers But Investors Need Patience
- USA Today’s Digital Revival Is Gaining Steam, But With Plenty of Risk
Receive News & Ratings for Ambu A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambu A/S and related companies with MarketBeat.com's FREE daily email newsletter.
